Author

Eva Iglesias 1

1 Hospital Universitario Reina Sofía,Córdoba,Spain

Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Pilar Nos Mateu, Eva Iglesias, Isabel Vera, Antonio López-San Román, Jordi Guardiola, Carlos Taxonera, Miguel Mínguez, Mariló Martin-Arranz, Luisa de Castro, Sabino Riestra, Montserrat Rivero, Esther García-Planella, Xavier Calvet, Santiago García-López, Montserrat Andre

LONG-TERM OUTCOMES OF ADALIMUMAB THERAPY IN ULCERATIVE COLITIS PATIENTS BY PRIOR ANTI-TNF EXPOSURE

Carlos Taxonera, Eva Iglesias, Jose Fernando Muñoz Nuñez, Marta Calvo, Manuel Barreiro de Acosta, David Busquets, Xavier Calvet Calvo, Antonio Rodríguez, Ramón Pajares, Javier Gisbert, Pilar López Serrano, José Lázaro Pérez-Calle, Angel Ponferrada, Cristobal de la Coba, Fernando Bermejo, Maria Chaparro Sanchez, Cristina Alb

Clinical features, therapeutic requirements and evolution of patients with Crohn´s disease and upper digestive tract involvement (CROHNEX study)

Empar Sainz Arnau, Yamile Zabana, Isabel Miguel, Agnes Fernandez Clotet, Maria José Casanova, Maria Dolores Martín, Maria Dolores Picó, Erika Alfambra, Iago Rodríguez, Fernando Muñoz, Manuel Domínguez, Eva Iglesias, David Busquets, Ana Gutiérrez, Fiorella Cañete, Laura Núñez, Carlos Taxonera, Belen Beltran, Blau Camps, Xavier Calvet, Pablo Navarro, Margalida Calafat, Rocío Ferreiro-Iglesias, Carlos Gonzalez Muñoza, Beatriz Sicilia, Cristina Rodriguez, Ana Y. Carbajo, Manuel Van Domselaar, Raquel Vicente, Marta Piqueras, Mari Carmen Muñoz, Agueda Abad La Cruz, Alicia Algaba, Pilar Martinez, Milagros Vela, Beatriz Antolín, José María Huguet, Luis Bujanda, Rufo H. Lorente, Pedro Almela, Maria Jose Garcia, Patricia Ramírez de la Pirscina, Ramón Pajares, Isabel Pérez-Martínez, Alfredo J. Lucendo, Olga Merino, Jesús Legido, Isabel Vera, Victor Jair Morales, María Esteve

EFFICACY AND SAFETY OF THE SEQUENTIAL USE OF A SECOND AND THIRD ANTI-TNF DRUG IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Maria José Casanova, Maria Chaparro Sanchez, Miguel Mínguez, Elena Ricart, Carlos Taxonera, Santiago García-López, Jordi Guardiola Capon, Antonio López-San Román, Eva Iglesias, Pilar Nos, Beatriz Sicilia, Maria Isabel Vera, Joaquin Hinojosa, Sabino Riestra, Eugeni Domenech Morral, Xavier Calvet Calvo, José Lázaro Pérez-Call

SNP RS6105269, A NEW PROGNOSIS MARKERS FOR CROHN DISEASE

Patricia Aguilar-Melero, Jose Manuel Benitez, Eva Iglesias, Rosario Medina Medina, Isabel Salgueiro, Maria Luisa Garcia, Valle García-Sánchez

Item 1 - 5 / 5
1
We use cookies in order to provide you with a better browsing experience. This includes third-party cookies for traffic analyzation purposes. See here for more information.
OK